Prognostic value of PIK3CA gene assessment in tissue & plasma in metastatic colorectal cancer (mCRC)

被引：0
|
作者：
Brage, E. Teran [1 ]
Tocino, R. Vidal [1 ]
Puertas, P. Reguera [1 ]
Mateos, Y. Lopez [1 ]
Gutierrez, A. Lopez [1 ]
Hernandez, M. M. Abad [2 ]
Manzano, J. Sayagues [2 ]
Rodrigues, A. [1 ]
Montero-Gonzalez, J. [2 ]
Araujo, D. Morchon [1 ]
Gonzalez, J. C. Redondo [1 ]
Mejorada, R. Lozano [1 ]
Sanchez, E. Fonseca [1 ]
机构：
[1] Univ Hosp Salamanca, Med Oncol Dept, Salamanca, Spain
[2] Univ Hosp Salamanca, Dept Pathol, Salamanca, Spain
来源：
ANNALS OF ONCOLOGY | 2024年 / 35卷
关键词：
D O I：
10.1016/j.annonc.2024.05.116
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
105P
引用
收藏
页码：S49 / S49
页数：1
相关论文
共 50 条
  • [21] Coexisting KRAS and PIK3CA exon 20 mutations as a potential poor-prognosis factor in metastatic colorectal cancer (mCRC).
    Elez Fernandez, Maria Elena
    Argiles, Guillem
    Matito, Judit
    Mendizabal, Leire
    Moreno, Debora
    Jimenez, Jose
    Hernandez-Losa, Javier
    Macarulla, Teresa
    Capdevila, Jaume
    Alsina, Maria
    Sauri, Tamara
    Azaro, Analia
    Cruz Zambrano, Cristina
    Landolfi, Stefania
    Sanz, Enrique
    Ramon y Cajal, Santiago
    Nuciforo, Paolo
    Rodon, Jordi
    Tabernero, Josep
    Vivancos, Ana
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [22] Mutation patterns and prognostic analysis of BRAF/KRAS/PIK3CA in colorectal cancer
    Wang, Chengfeng
    Pan, Diling
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2022, 36 (06)
  • [23] Prognostic value of PIK3CA mutational status in tissue & plasma in HR+/HER2-breast cancer (BC)
    Lozano Mejorada, R.
    Teran Brage, E.
    Munoz Leon, J. A.
    Lopez Gutierrez, A.
    Figuero Perez, L.
    Rodrigues Francoso, A.
    Seijas Tamayo, R.
    Morchon Araujo, D.
    Garijo Martinez, M. D. C.
    Roldan-Ruiz, J.
    Abad Hernandez, M. M.
    Sancho de Salas, M.
    Fonseca Sanchez, E.
    Rodriguez Sanchez, C. A.
    ANNALS OF ONCOLOGY, 2023, 34 : S389 - S389
  • [24] Elucidating the prognostic significance of KRAS, NRAS, BRAF and PIK3CA mutations in Chinese patients with metastatic colorectal cancer
    Ma, Brigette B.
    Mo, Frankie
    Tong, Joanna H.
    Wong, Ashley
    Wong, S. C. Cesar
    Ho, Wing M.
    Wu, Cherry
    Lam, Polly W. Y.
    Chan, K. F.
    Chan, Timothy S. K.
    Tsui, Wilson M. S.
    Tsang, Alex K. H.
    Fung, Mandy N. S.
    Chan, Anthony T. C.
    To, Ka Fai
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2015, 11 (02) : 160 - 169
  • [25] Mutations of the PIK3CA gene in hereditary colorectal cancers
    Miyaki, Michiko
    Iijima, Takeru
    Yamaguchi, Tatsuro
    Takahashi, Keiichi
    Matsmnoto, Hiroshi
    Yasutome, Michiya
    Funata, Nobuaki
    Mori, Takeo
    INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (07) : 1627 - 1630
  • [26] Frequent PIK3CA gene amplification and its clinical significance in colorectal cancer
    Jehan, Zeenath
    Bavi, Prashant
    Sultana, Mehar
    Abubaker, Jehad
    Bu, Rong
    Hussain, Azhar
    Alsbeih, Ghazi
    Al-Sanea, Nasser
    Abduljabbar, Alaa
    Ashari, Luai H.
    Alhomoud, Samar
    Al-Dayel, Fouad
    Uddin, Shahab
    Al-Kuraya, Khawla S.
    JOURNAL OF PATHOLOGY, 2009, 219 (03): : 337 - 346
  • [27] Polymorphic GT dinucleotide repeat in the PIK3CA gene and risk of colorectal cancer
    Parsafar, Soha
    Hematti, Simin
    Ghorbani, Fateme
    Safari, Forousan
    Tavassoli, Manoochehr
    CANCER BIOMARKERS, 2015, 15 (04) : 397 - 403
  • [28] PIK3CA and TP53 gene mutations in patients with metastatic colorectal cancer from Northeast Romania
    Afrasanie, V.
    Stratulat, T. Alexa
    Marinca, M.
    Gafton, B.
    Froicu, E.
    Morar, L.
    Lefter, A.
    Rusu, C.
    ANNALS OF ONCOLOGY, 2022, 33 : S355 - S355
  • [29] PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer
    Xu, Jian-Ming
    Wang, Yan
    Wang, You-Liang
    Wang, Yan
    Liu, Tao
    Ni, Ming
    Li, Man-Sheng
    Lin, Li
    Ge, Fei-Jiao
    Gong, Chun
    Gu, Jun-Yan
    Jia, Ru
    Wang, He-Fei
    Chen, Yu-Ling
    Liu, Rong-Rui
    Zhao, Chuan-Hua
    Tan, Zhao-Li
    Jin, Yang
    Zhu, Yun-Ping
    Ogino, Shuji
    Qian, Zhi-Rong
    CLINICAL CANCER RESEARCH, 2017, 23 (16) : 4602 - 4616
  • [30] PIK3CA alterations in metastatic breast cancer (mBC)
    Albanell, J.
    Casadevall, D.
    Sokol, E. S.
    Albacker, L. A.
    Elvin, J. A.
    Vergilio, J-A.
    Killian, J. K.
    Ngo, N.
    Lin, D.
    Ramkissoon, S.
    Severson, E.
    Ali, S. M.
    Schrock, A. B.
    Chung, J.
    Reddy, P.
    Miller, V. A.
    Alexander, B. M.
    McGregor, K.
    Ross, J. S.
    Leyland-Jones, B.
    ANNALS OF ONCOLOGY, 2019, 30 : 104 - +
12345